Key points Cardiovascular outcome trials in individuals with type 2 diabetes mellitus demonstrate that glucagon-like peptide 1 (GLP1) receptor (GLP1R) agonists reduce the rates of non-fatal myocardial infarction, non-fatal stroke and cardiovascular death
Sterling J, Hua P, Dunaief JL, Cui QN, VanderBeek BL
J.WegleiterT.MooreD
However, without integration with behavioral medicine and lifestyle changes, these benefits will likely end when patients stop taking GLP-1 medications
Medically Reviewed By: Dr Jana Lim | MBChB, MMed (FM) | Board-Accredited Family Physician MBChB, MMed (FM) | Board-Accredited Family Physician Semaglutide is a prescription-only medication that can help manage blood sugar levels and support long-term metabolic health in adults with a higher BMI , when it is considered medically suitable
Your body won't experience a dangerous overdose from this timing shift, and attempting to compensate by missing the following week's injection could actually destabilize your weight loss progress
